Cell cycle-dependent expression of TAP1, TAP2, and HLA-B27 messenger RNAs in a human breast cancer cell line

Cancer Research

Volumn 56, Issue 19, 1996, Pages 4358-4361

  Alpan, Recep S ^a   Zhang, Ming ^a   Pardee, Arthur B ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; HLA B27 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; PROTEASOME;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; BREAST CANCER; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENDOPLASMIC RETICULUM; GROWTH REGULATION; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; IMMUNOTHERAPY; PRIORITY JOURNAL;

ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; ATP-BINDING CASSETTE TRANSPORTERS; BREAST; BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; EPITHELIAL CELLS; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HLA-B27 ANTIGEN; HUMANS; NEOPLASM PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 0029740214     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Liang, P, and Pardee, A. B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science (Washington DC), 257: 967-971, 1992
2. Liang, P., Averboukh, L., and Pardee, A B. Distribution and cloning of eucaryotic mRNAs by means of differential display, refinements and optimization. Nucleic Acids Res , 21: 3269-3275, 1993.
3. 1 by using the differential display method Mol. Med., 2: 469-478, 1996.
4. Heemels, M , and Ploegh, H. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu Rev. Biochem., 64: 463-491, 1995
5. Howard, J. C., and Seelig, A Peptides and the proteasome. Nature (Lond.), 365: 211-212, 1993.
6. Goldberg, A. L Functions of proteasome: the lysis at the end of the tunnel. Science (Washington DC), 268: 522-523, 1995
7. Bijlmakers, M. J , and Ploegh, H. L. Putting together a MHC class I molecule. Curr. Opin Cell Biol , 5 21-26, 1993.
8. Szots, H., Riethmuller, G , Weiss, E., and Meo, T Complete sequence of HLA-B27 cDNA identified through the characterization of structural markers unique to the HLA-A, -B, and -C allelic series. Proc. Natl. Acad Sci, USA, 83: 1428-1432, 1986.
9. Rotem, Y. R , Winograd, S., Sela, S., Coligan, J. E., and Ehrlich, R. Downregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus 12 J. Exp. Med., 180: 477-488, 1994.
10. Hill, A., Jugovic, P., York, I , Russ, G., Bennink, J., Yewdell, J , Ploegh, H., and Johnson, D. Herpes simplex virus turns off the TAP to evade host immunity Nature (Lond.), 375 411-415, 1995
11. Kovacsovicbankowski, M , and Rock, K L. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules Science (Washington DC), 267: 243-246, 1995
12. Oliver, R T , and Nouri, A M. T cell immune response to cancer and its relevance for immunodiagnosis and therapy Cancer Surv , 13 173-204, 1992.
13. Band, V , and Sager, R. Distinctive traits of normal and tumor derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc. Natl. Acad. Sci USA, 86: 1249-1253, 1989
14. Crissman, H. A., and Steinkamp, J. A. Rapid simultaneous measurement of DNA, protein and cell volume in single cells from large mammalian cell populations. J Cell Biol., 59 766-771, 1973.
15. 1 to multiple cell cycles by lovastatin Cancer Res., 51 3602-3609, 1991
16. Zhang, M., Zhiqiang, Z , Maass, N , and Sager, R. Differential expression of elafin in human normal mammary epithelial cells and carcinomas is regulated at the transcriptional level. Cancer Res., 55: 2537-2541, 1995
17. Ausubel, R , Brent, R., Kingston, R E , Moore, D. D , Seidman, J. G., Smith, J. A., and Struhl, K Current Protocols in Molecular Biology, New York: Green Publishing Associates and Wiley-Interscienee, 1988.
18. Male, D. K., Pryce, G., and Hughes, W. Antigen presentation in brain: MHC induction on brain endothelium and astrocytes compared. Immunology. 60: 453-549, 1987.
19. Neumann, H., Cavalie, A , Jenne, D. E., and Wekerle, H Induction of MHC class-I genes in neurons Science (Washington DC), 269: 549-552, 1995
20. Burnet, F M. The concept of immunological surveillance Prog. Exp. Tumor Res., 13: 1-27, 1970
21. Boon, T., Cerottini, J C., Eynde, B. V., Bruggen, P., and Pel, A. V. Tumor antigens recognized by T lymphocytes. Annu. Rev Immunol., 12: 337-365, 1994.
22. Restfilo, N. P , Esquivel, F , Kawakami, Y , Yewdell, J. W., Mule. J. L., Rosenberg, S. A , and Bennink, J R. Identification of human cancers deficient in antigen processing J. Exp. Med. 177: 265-272, 1993.
23. Gabathuler, R , Reid, G., Kolams, G., Driscoll, J., and Jefferies, W. A. Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing. J. Exp. Med., 180: 1415-1425, 1994
24. Klein, G , and Klein. E. Evolution of tumors and the impact of molecular oncology. Nature (Lond.), 315: 190-195, 1985
25. 1 events and regulation of cell proliferation. Science (Washington DC), 246: 603-608, 1989
26. Elliot, B. E.,- Carlow, D. A., Rodricks, A , and Wade, A. Perspectives on the role of MHC antigens in normal and malignant cell development. Adv. Cancer Res., 53: 181-245, 1989.
27. Branch, P., Bicknell, D. C., Rowan, A , Bodmer, W. F , and Karran, P. Immune surveillance in colorectal carcinoma Nat. Genet , 9 321-322, 1995
28. Kaklamanis, L., Leek, R., Koukourakis, M., Gatter, K C , and Harris, A L. Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer Cancer Res., 55: 5191-5194, 1995
29. Ogmundsdottir, H. M., Petursdottir, I., and Gudmundsdottir, I. Interactions between the immune system and breast cancer Acta Oncol., 34 647-650 1995